Pila Pharma AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
October 26, 2022 at 02:00 pm IST
Pila Pharma AB (publ) reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was SEK 0.281 million. Net loss was SEK 5.92 million compared to SEK 5.58 million a year ago. Basic loss per share from continuing operations was SEK 0.37 compared to SEK 0.39 a year ago. Diluted loss per share from continuing operations was SEK 0.37 compared to SEK 0.39 a year ago.
For the nine months, sales was SEK 1.47 million. Net loss was SEK 22.76 million compared to SEK 11.79 million a year ago. Basic loss per share from continuing operations was SEK 1.41 compared to SEK 0.91 a year ago. Diluted loss per share from continuing operations was SEK 1.41 compared to SEK 0.91 a year ago.